Jade Biosciences, Inc. — Investor Relations & Filings
Filings indexed
457
across all filing types
Latest filing
2026-05-15
Regulatory Filings
Country
US
United States of America
Listing
US
JBIO
Jade Biosciences, Inc. is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases, inflammation, and immunology. The company aims to create transformative, disease-modifying treatments to address significant unmet medical needs and redefine the standard of care. Its pipeline features novel biologics, with the lead candidate, JADE101, being developed for the treatment of immunoglobulin A nephropathy (IgAN). JADE101 is an inhibitor of the cytokine APRIL (A PRoliferation-Inducing Ligand). The company's programs are based on discovery-stage assets licensed from Paragon Therapeutics.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 424B3 | 2026-05-15 | English | |
| S-8 - Jade Biosciences, Inc. (0001798749) (Filer) | 2026-05-07 | English | |
| S-3 - Jade Biosciences, Inc. (0001798749) (Filer) | 2026-05-07 | English | |
| S-3 - Jade Biosciences, Inc. (0001798749) (Filer) | 2026-05-07 | English | |
| 424B3 - Jade Biosciences, Inc. (0001798749) (Filer) | 2026-05-07 | English | |
| 8-K - Jade Biosciences, Inc. (0001798749) (Filer) | 2026-04-22 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46362227 | 424B3 | 2026-05-15 | English | ||
| 43597502 | S-8 - Jade Biosciences, Inc. (0001798749) (Filer) | 2026-05-07 | English | ||
| 43589318 | S-3 - Jade Biosciences, Inc. (0001798749) (Filer) | 2026-05-07 | English | ||
| 43582556 | S-3 - Jade Biosciences, Inc. (0001798749) (Filer) | 2026-05-07 | English | ||
| 43524504 | 424B3 - Jade Biosciences, Inc. (0001798749) (Filer) | 2026-05-07 | English | ||
| 35226913 | 8-K - Jade Biosciences, Inc. (0001798749) (Filer) | 2026-04-22 | English | ||
| 31760251 | SCHEDULE 13G Filing | 2026-02-17 | English | ||
| 31760104 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 31760021 | SCHEDULE 13G Filing | 2026-02-17 | English | ||
| 31760250 | 4 Filing | 2026-02-13 | English | ||
| 31760064 | 4 Filing | 2026-02-13 | English | ||
| 31760005 | 4 Filing | 2026-02-13 | English | ||
| 31759976 | 4 Filing | 2026-02-13 | English | ||
| 31759919 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 31760179 | SCHEDULE 13G/A Filing | 2026-01-30 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Delta-Fly Pharma, Inc.
Biopharmaceutical firm developing novel anticancer drugs fr…
|
4598 | JP | Professional, scientific and te… |
|
DELTA GOLD TECHNOLOGIES LIMITED
Develops and licenses IP for the quantum computing sector u…
|
DGQ | GB | Professional, scientific and te… |
|
DG INNOVATE PLC
Develops sustainable technologies for electric mobility and…
|
DGI | GB | Professional, scientific and te… |
|
Dianthus Therapeutics, Inc. /DE/
Clinical-stage biotech developing therapies for severe auto…
|
DNTH | US | Professional, scientific and te… |
|
DIMERIX LIMITED
Develops GPCR-targeted therapies for inflammatory kidney an…
|
DXB | AU | Professional, scientific and te… |
|
Dogwood Therapeutics, Inc.
A biotech company developing novel therapeutics for pain an…
|
DWTX | US | Professional, scientific and te… |
|
DORSAVI LTD
Develops clinical-grade wearable sensors and software for h…
|
DVL | AU | Professional, scientific and te… |
|
DreamCIS INC.
Contract research organization for pharma, biotech, and med…
|
223250 | KR | Professional, scientific and te… |
|
DT&CRO CO., Ltd.
A full-service CRO providing non-clinical and clinical stud…
|
383930 | KR | Professional, scientific and te… |
|
Dundee Sustainable Technologies Inc.
Develops proprietary, sustainable metallurgical processes f…
|
DST | CA | Professional, scientific and te… |
Jade Biosciences, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33383/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33383 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33383 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33383 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33383}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Jade Biosciences, Inc. (id: 33383)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.